Concepedia

S. S. Yang

SS

4

Publications

134

Citations

4

H-Index

1972

Active since

Affiliations

National Cancer Institute(Current)

S. S. Yang is an author at National Cancer Institute specializing in clinical microbiology, medicine, and antimicrobial drug discovery.

ORCID

Top concepts

Publications per year

1972–2024

4

Publications

4

Rifamycin Antibiotics: Inhibitors of Rauscher Murine Leukemia Virus Reverse Transcriptase and of Purified DNA Polymerases From Human Normal and Leukemic Lymphoblasts

S. S. Yang, Francisco Herrera, R. Graham Smith et al. · JNCI Journal of the National Cancer Institute · 1972 · 67 citations

, , +24

Highly potent oxathiin carboxanilide derivatives with efficacy against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus isolates

Robert W. Buckheit, M Snow, Valerie Fliakas-Boltz et al. · Antimicrobial Agents and Chemotherapy · 1997 · 40 citations · Full text

MIF/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK–ERK and AP-1 pathways

S. S. Yang, Wei Tang, Azadeh Azizian et al. · Carcinogenesis · 2024 · 14 citations

The death education needs of patients with advanced cancer: a qualitative research

S. S. Yang, Chao Yan, Jing Li et al. · BMC Palliative Care · 2024 · 13 citations · Full text

Rows per page

1–4 of 4